DNA X, Inc. (SONM)
Official siteFINANCIAL SERVICES • COMMUNICATION EQUIPMENT • NASDAQ
Market Cap: $3.13M
Last updated: Nov 17, 2026 at 4:10 PM ET
DNA X, Inc. (SONM) Statistics
DNA X (SONM) has a market cap of $3.13M and an enterprise value of $4.63M. It earned -$8.55M on revenue of -$27.92M over the last 12 months.
Total Valuation
Enterprise value is 47.92% above the market cap, as debt exceeds cash.
| Market Cap | $3.13M |
|---|---|
| Enterprise Value | $4.63M |
| Latest price (Nov 17, 2026) | $2.07 |
Key Dates
The next earnings report is expected on Apr 12, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Apr 12, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 13, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 78.81% over 52 weeks and trades 35.31% below its 50-day average.
| Beta (1Y) | 0.56 |
|---|---|
| 52-Week Change | -78.81% |
| 1-Month Change | -37.46% |
| 3-Month Change | -38.76% |
| 6-Month Change | -51.87% |
| 5-Year Change | -99.33% |
| Total Return (1Y) | -78.81% |
| Total Return (3Y CAGR) | -74.57% |
| Total Return (5Y CAGR) | -63.16% |
| Return vs SPY (1Y) | -89.11% |
| Max Drawdown (1Y) | -78.42% |
| Max Drawdown (3Y) | -98.89% |
| Sharpe Ratio (1Y) | -1.22 |
| Correlation with SPY (1Y) | 0.06 |
| 50-Day Average | $3.20 |
| 200-Day Average | $3.97 |
| 52-Week Range | $2.02 to $9.22 |
| RSI (14 Days) | 29.6 |
| Average Volume (20 Days) | 14.13K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 0.57x current liabilities.
| Current Ratio | 0.57x |
|---|---|
| Quick Ratio | 0.57x |
Returns and Efficiency
Return on invested capital is -346.10% over the last 12 months, against a 5-year average of -15.83%.
| Return on Assets (ROA) | -189.22% |
|---|---|
| Return on Invested Capital (ROIC) | -346.10% |
| ROA (5Y Average) | -50.43% |
| ROIC (5Y Average) | -15.83% |
Scores
SONM has an Altman Z-Score of -102.86, in the distress zone below 1.81, and a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -102.86 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 1 of 9 |
| Piotroski Strength | Weak |
Income Statement
Revenue was -$27.92M over the last 12 months.
| Revenue | -$27.92M |
|---|---|
| Gross Profit | -$9.21M |
| Operating Income | -$4.21M |
| Pretax Income | -$6.38M |
| Net Income | -$8.55M |
| EBITDA | -$2.49M |
| EBIT | -$5.12M |
Trailing 12 months through Jun 30, 2026.
Balance Sheet
| Cash and Equivalents | $900.00K |
|---|---|
| Total Debt | $2.40M |
| Net Debt | $1.50M |
| Net Debt Per Share | $1.11 |
| Working Capital | -$2.23M |
| Shareholder Equity | -$1.23M |
| Tangible Book Value | -$2.61M |
| Total Assets | $4.52M |
| Total Liabilities | $5.75M |
Balance sheet as of Jun 30, 2026.
Cash Flow
| Operating Cash Flow | -$14.51M |
|---|---|
| FCF Per Share | -$9.75 |
| Depreciation and Amortization | $2.63M |
Trailing 12 months through Jun 30, 2026.
Dividends and Yields
SONM does not pay a dividend.
| Buyback Yield | -168.75% |
|---|---|
| Shareholder Yield | -168.75% |
Stock Splits
The last split was a 1-for-18 reverse split on Oct 27, 2025.
| Last Split Date | Oct 27, 2025 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:18 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About SONM
What is SONM's market cap?
DNA X has a market cap of $3.13M. Its enterprise value, which adds debt and subtracts cash, is $4.63M.
How many shares of SONM are outstanding?
DNA X has 1.35M shares outstanding.
Does SONM pay a dividend?
No. DNA X does not pay a dividend.
How much debt does SONM have?
DNA X has $2.40M of total debt and $900.00K of cash and equivalents, a net debt position of $1.50M.
SONM pages: Overview, Charting, Earnings, Financials, Statistics, Competitors